P3.01-035 Post-Marketing Observational Study of Japanese Patients with EGFR Mutation-Positive (EGFRm+) NSCLC Treated with Daily Afatinib (Final Report)

Autor: Yamamoto, N., Nukiwa, T., Nakanishi, Y., Gemma, A., Mizushima, M., Takayama, T., Kumazawa, J., Azuma, H., Tamura, K.
Zdroj: In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S2213-S2214
Databáze: ScienceDirect